We investigated the effects of lithium ion (Li+) on muscarinic receptor-mediated nitric oxide (NO) generation, and guanylate cyclase (GCase) activation using the mouse neuroblastoma clone, NIE-115. The levels of released NO were determined by measuring the levels of nitrite/nitrate in the incubation medium, and the activity of GCase was measured with an assay for cellular cyclic [3H] GMP levels. We determined that Li+ had no effects on muscarinic receptor-activated elevation of nitrite/nitrate levels, which were significantly inhibited
Lithium (Li+) is often prescribed for patients with manic depressive illness (MOl), and has a preventive effect for recurrence of MOl (Cade 1949; Schou 1968 ). The precise mechanisms underlying the effects of Li + in such psychiatric illnesses as MOl remain unknown. Hokin and Hokin (1953) reported that activation of mus carinic receptors stimulated the breakdown of phospha-by 100 11M L-NG-monomethylarginine, although it has been reported that Li+ inhibits muscarinic receptor activated cyclic GMP formation in the cells. In addition, Li+ inhibited the cyclic GMP formation induced by an NO donor, sodium nitroprusside (SNP), in both intact cells and a crude cellular homogenate; thus, the inhibition by Li+ of muscarinic receptor-mediated cyclic GMP synthesis appeared to be at the level of GCase, but not NO synthase. [Neuropsychopharmacology 11:119-124, 1994J tidylinositol (PI), and it has been shown that Li+ caused the accumulation of the product of this break down, myo-inositol-1-phosphate, in the brain through inhibition of myo-inositol-1-phosphatase (Hallcher and Sherman 1980; Berridge 1984) . Although many inves tigations have focused on the PI cycle as the site of ther apeutic action of this ion, no consensus as to the basic mechanism of Li + actions has yet been established.
We have already reported that Li + signifIcantly in hibited cyclic GMP formation induced by stimulation with carbamylcholine, a muscarinic receptor agonist, by using a mouse neuroblastoma clone: NlE-115 cells (Kanba and Richelson 1984; Kanba et al. 1986 ). In addi tion, when sodium channel was activated, Li + had an increased potent intracellular effect (Kanba et al. 1991) . We hypothesized that the inhibitory action of Li+ on cyclic GMP formation may be associated with its clini cal efficacy and toxicity, and that the action may become 0893-133X/94/$7.00 increasingly potent in pathologically-active neurons un derlying manic-depressive disorder.
Conversely, in many types of cells, guanylate cy clase (GCase) is activated by nitric oxide (NO), which is produced by nitric oxide synthases (NOS) from L-arginine (Knowles et al. 1989; Garthwaite 1991) . Ac tivation of the muscarinic receptors on N1E-115 cells can also induce production and release of NO by medi ating the activation of NOS (Arroyo and Forray 1991) . Despite our results and those of others, we hypothe sized that the inhibitory effects of Li + on cyclic GMP formation are due to inhibition of NO synthesis, or GCase activation. The present studies were designed to investigate the mechanism by which Li+ inhibits the muscarinic receptor-mediated cyclic GMP formation. First, to assess the possibility that Li + inhibits receptor mediated NO synthesis, we examined if Li + inhibits muscarinic receptor-mediated NO generation in N1E-115 cells by measuring the nitrite/nitrate levels in the incubation medium. Second, in order to determine if Li + directly inhibits activation of guanylate cyclase, we determined the guanylate cyclase activity in both in tact cells and a crude homogenate of N1E-115 cells COn taining several concentrations of Li + by measuring the levels of cyclic GMP elicited by SNP.
METHODS

Cell Culture
NlE-115 cells (passages 12-14) were cultured in Dul becco's MEM as described previously (Kanba and Richelson 1984) . The cells were used for the experiment when they had reached a state of confluence in 25 cm 2 culture flasks (Corning).
Assay of Nitrite/Nitrate Levels in the Incubation
Medium of NlE-115 Cells
After the cells had been washed three times with 3 mI of Hanks' solution (137 mM NaCl, 5.4 mM KCl, 1.3 mM CaCh, 0.8 mM MgS04, 0.338 mM Na 2 HP04, 0.4 mM KH 2 P04, 5.6 mM glucose, 4.2 mM NaHC0 3 , pH 7.4), they were preincubated at 37°C for 30 min in 3 mI of Hanks' solution. Five-hundred microliters of the incu bation medium were collected, and 2.5 !J.l of 100 mM L-NG-monomethylarginine (L-NMMA), for inhibition of NOS, or vehicle was added. The cells were then stimulated with carbamylcholine to achieve 0.01, 0.03, 0.1, 0.3, 1, or 3 mM as a fmal concentration. Five-hun dred microliters of the incubation medium were col lected again at 30 seconds after stimulation.
In another series of experiments, after the cells had been washed three times as described previously, they were pre incubated at 37°C for 30 minutes in 3 mI of Hanks' solution containing various concentrations of NEUROPSYCHOPHARMACOLOGY 1994-VOL. 11, NO.1 lithium chloride (LiCl), sodium chloride (NaCl), or am monium chloride (NH4Cl). Five-hundred microliters of the incubation medium were collected immediately be· fore and 30 seconds after stimulation with 1 mM car bamylcholine. Two and one half microliters of 100 mM L-NMMA, or vehicle were added immediately before stimulation.
When the series of experiments had been com pleted, the numbers of cells were counted after scrap ing. Nitrite/nitrate concentrations in the incubation medium were quantitated with an automated system based on the Griess reaction (Hishikawa et al. 1992) .
The values obtained by subtracting nitrite/nitrate lev els before stimulation from those obtained after stimu lation were regarded as nitrite/nitrate derived from the cells.
Assay of Cyclic GMP Levels in Intact NIE-115 Cells
NIE-115 cells were cultured as described previously. Detached and washed N1E-115 cells were suspended in 3 mI of physiological iso osmolar phosphate buff er containing saline with glucose and sucrose (PBS; 110 mM NaCl, 5.3 mM KCl, 1.8 mM CaCh, 1 mM MgCh, 25 mM glucose, 2 mM Na 2 HP04; pH adjusted to 7.35; osmolarity adjusted to 335 ± 5 mOsmol with sucrose) at 37°C (3-5 x 106 cells/mIl. The cells were transferred to a 25-mI Erlenmeyer flask and 30 !J.Ci of [3H]guanine was added. The cells were placed in a shaker bath at 37°C and incubated for 45 min. After labeling with [3H]guanine, the cells were centrifuged gently, and the supernatant containing excess radioactivity was aspi rated. The pelle ted cells were then resuspended in PBS at 37°C to about 3 to 4 X 105 cells/mI, and were dis tributed into the wells of a multiwell plate in 320-!J.I ali quots. Several concentrations of LiCl, NaCl, and NH4Cl were then added in a 100-!J.l aliquot, and the cells were further incubated at 37°C for 30 minutes. The cells were stimulated with sodium nitroprusside (SNP; an 80-!J.I aliquot), to achieve 10, 25, 50, 100, 200, 30 0, or 400 !J.M as the fmal concentration, for 30 seconds. The assay was stopped with the addition of 50 !J.1 of 50% trichloroacetic acid. The levels of cyclic [3H]GMP were then determined as described previously (Richelson et al. 1978) .
Assay of Guanylate Cyclase Activity in Homogenates of NIE-115 Cells
Detached and washed cells were suspended in 50 mM Tris-HCI buffer (pH 7.6 at 37°q to about 2 to 3 X 106 cells/mI. The cells were then sonicated for 30 seconds (setting no. 3, Ultrasonic Cell Disrupter, Kontes Glass Co., Vineland, NJ) on ice. The assay of GCase activity was begun with the addition of 50 !J.l of the cell homog enate to the reaction cocktail. The fmal volume of the '£ a; 300 assay was 150 III and consisted of the following: 50 mM Tris-HCl (pH 7.6); 5 mM MgCh; 0.5 mM 3-isobutyl-1-methylxanthine; 2.5 mM cyclic GMP; 5 mM creatine phosphate; 0.6 U of creatine phosphokinase; 0.25 mM Grp; 3 to 4 X 105 dpm of [3H1GTP; several concentra tions of LiCl and SNP. Incubations were carried out at 37°C for 5 minutes and reactions were stopped by the addition of 30 III of 50% trichloroacetic acid. The cyclic PH1GMP formed was determined as described previ ously (Richelson et al. 1978) . 
RESULTS
Effects of LiCI on Muscarinic Receptor-activated Nitrite/Nitrate Derived from NIE-115 Cells
Carbamylcholine enhanced the levels of nitrite/nitrate in the incubation medium in a dose dependent man ner, and the elevation of nitrite/nitrate levels was The data are mean ± SEM of quadruplicate independent experiments. After the cells had been in cubated with each concentration of LiCl, NaCl, or NH4Cl for 30 minutes, they were stimulated with 1 mM carbamylcholine. Immediately before stimulation, 100 �M L-NMMA, or vehicle were added. The levels of nitrite/nitrate in the incubation medium, that was collected 30 seconds after stimula tion, were determined using the Griess reaction. signifIcantly inhibited by preincubation with 100 J.lM L-NMMA (Figure 1 ). In intact N1E-115 cells, LiCl, as well as NaCl and NH4Cl, exerted no signifIcant inhibi tory effects on carbamylcholine (1 mM)-stimulated ele vation of nitrite/nitrate levels ( Table 1) .
Effects of LiCI on SNP-induced Cyclic GMP Levels in Intact NIE-l1S Cells
In intact cells, elevation of the cyclic GMP levels elicited by 300 JlM SNP was inhibited by pretreatment with sev eral concentrations of LiCl for 30 minutes in a dose dependent manner (Figure 2 ). IC 5 0 was 10 ± 2 rnM (n = 4). NaCl and NH4Cl had no signifIcant inhibitory effects, but did appear to suppress the response at lev els higher than 30 mM because of high osmolarity (Fig  ure 2) . Elevation of the cyclic GMP levels elicited by 300 J.lM SNP was maximal in intact cells. Concentrations of SNP higher than 400 J.lM decreased this response (Figure 3 ). LiCl inhibited cyclic GMP formation induced by various concentrations of SNP, and this inhibition by LiCl was not restored by SNP doses as high as 300 J.lM (Figure 3 ).
Effects of LiCI on Cyclic GMP Levels in a Crude Homogenate of NIE-l1S Cells
In a crude homogenate of N1E-115 cells, LiCl inhibited SNP (from 10-8 to 10-5 M)-activated cyclic GMP for mation in a dose-dependent manner (Figure 4 ). Up to 10-5 M SNP did not restore the inhibition by 10, 25, or 50 mM LiCl, though a concentration higher than 10-4 M did appear to restore this inhibition. 
DISCUSSION
We investigated the effects of Li + on muscanruc receptor-mediated NO generation and activation of GCase using a mouse neuroblastoma clone, N1E-115. We previously reported that Li+ inhibits muscarinic receptor-activated cyclic GMP formation in N1E-115 cells (Kanba and Richelson 1984) . There is agreement that activation of soluble GCase after receptor activa tion is a consequence of receptor mediated Ca 2 + influx and activation of NOS (Dunnwiddie and Hoffer 1982; Knowles et al. 1989 ). Although the mechanism by which Li + inhibits cyclic GMP formation remains speculative, Li + is known to increase rather than decrease cellular Ca 2 + levels by affecting transmembrane Na + /Ca 2 + ex change processes (Aldenhoff and Lux 1984) . Conse quently, we hypothesized that Li+ may exert its inhibi tory actions by inhibiting the activation of either NOS or GCase. Because carbamylcholine enhanced the levels of ni trite/nitrate in a dose-dependent manner and the in crease in these levels was signifIcantly inhibited by preincubation with 100 J.lM L-NMMA (Figure 1) , it was suggested that the elevated nitrite/nitrate levels reflect NO production/release from L-arginine following the activation of muscarinic receptors. Because incubation with LiCl for 30 minutes, which appeared to be enough time to inhibit receptor-mediated cyclic GMP formation (Kanba et al. 1986 ), did not reduce nitrite/nitrate levels in the incubation medium (Table 1) , it was suggested that Li + does not affect receptor-mediated activation of NOS and that interference with the activation of NOS cannot explain the described inhibitory effects of Li + on cyclic GMP formation.
It is known that certain cofactors including tetra hydrobiopterine, calcium-calmodulin, flavin mono nucleotide, flavin adenine dinucleotide, and heme are necessary for NO synthase to be activated (Nathan 1992) . Considering the effects of Li + on Ca2+ influx (Aldenhoff and Lux 1984) , it was expected that Li+ might change the activity of NOS by affecting activa tion of the calcium-calmodulin system. However, our results indicate that Li + does not affect the receptor mediated activation of NOS. We cannot explain why Li+ did not exert the expected action on NO synthe sis, despite its effects on Ca2+ influx.
The ICso of LiC! for cyclic GMP formation induced by NO donor SNP in intact cells was consistent with that for carbamylcholine-induced cyclic GMP formation in intact cells, which we previously reported ( Figure   2 ) (Kanba and Richelson 1984) . Because dose-dependent inhibition by LiC! was observed in both the intact cells and a crude cellular homogenate (Figure 3, Figure 4 ), we speculate that Li + is capable of inhibiting cyclic GMP formation without mediating receptor activation. SNP is known to activate GCase by producing NO en zymatically in the cells. Several oxidizing agents, such as methylene blue and KFe(CN)6, also inhibit SNP induced cyclic GMP accumulation by converting NO to higher nitrogen oxides (Waldmann and Murad 1987) . Li + does not share these oxidizing properties and may act via other mechanisms; therefore, these fIndings sug gest that LiC! acts directly on GCase to inhibit the NO mediated activation.
Inhibition of cyclic GMP formation by LiC! was not restored by stimulation with 300 IlM SNP in intact cells. Because of SNP's inherent cytotoxicity in intact cells, we did not examine if this response was restored at con centrations of SNP higher than 400 IlM. It did appear to be restored by higher concentrations of SNP in the experiments using cell homogenates. The reason for the biphasic inhibition curve is unknown. It is possible that Li+ acts directly at the catalytic subunit of GCase by modifying substrate binding at lower levels and that Li+ affects the activation subunit by interfering with reactions of NO at higher levels. In addition, because SNP is known to activate soluble GCase through mul tiple catalytic sites with different Km values (Lewicki et aI. 1982) , inhibition of GCase activity may occur at diff erent catalytic sites depending upon the concentra tion of Li+.
The clinically effective concentration of Li + is much lower than the GCase inhibiting dose observed in this study; however, a recent report showed that ther apeutic concentrations of Li + inhibit SNP-induced ac cumulation of cyclic GMP in human lymphocytes (Schubert et al. 1991) . Jope et al. (1992) reported that cyclic GMP production was reduced by acute and chronic administration of a therapeutic concentration of Li +. Furthermore, methylene blue which also inLithium and Nitric Oxide 123 hibits SNP-induced cyclic GMP formation has been proven to have a prophylactic effect in manic-depres sive disorder like Li + (Naylor et al. 1986 ); thus, it is in teresting to know if other cyclic GMP inhibiting agents would have a similar clinical effect.
In summary, it was suggested that Li+ directly in hibits GCase activation without inhibition of receptor mediated NO generation.
